Literature DB >> 25327779

Activation of NLRP3 and AIM2 inflammasomes in Kupffer cells in hepatic ischemia/reperfusion.

Hyo-Yeon Kim1, Seok-Joo Kim, Sun-Mee Lee.   

Abstract

Inflammasome activation by danger signals in ischemia/reperfusion (I/R) injury is responsible for the sterile inflammatory response. Signals triggering formation and activation of the inflammasome involve the generation of oxidative stress. The aim of this study was to examine the molecular mechanisms of inflammasome activation and the involvement of reactive oxygen species in hepatic I/R. I/R induced the formation of nucleotide-binding domain leucine-rich repeat containing family pyrin domain containing 3 (NLRP3) and absent in melanoma 2 (AIM2) inflammasomes and the subsequent serum release of interleukin 1β. Pannexin-1 inhibitor and anti-cathepsin B antibody attenuated I/R-induced inflammasome activation and hepatic injury. The expression of the thioredoxin-interacting protein gene and the interaction between NLRP3 and the thioredoxin-interacting protein increased after I/R. Treatment with the antioxidant N-acetylcysteine significantly attenuated protein conversion of interleukin 1β after hepatic I/R. Moreover, pannexin-1 protein expression and cathepsin B release were strongly attenuated by N-acetylcysteine. The depletion of Kupffer cells with gadolinium chloride markedly decreased NLRP3 and AIM2 inflammasome expression and activation of their signaling pathways, and also reduced the level of caspase-1 protein in F4/80-positive cells. Our findings suggest that reactive-oxygen-species-mediated activation of NLRP3 and AIM2 inflammasomes leads to I/R-induced inflammatory responses in which Kupffer cells play a crucial role.
© 2014 FEBS.

Entities:  

Keywords:  inflammasome; interleukin-1β; ischemia/reperfusion; liver; reactive oxygen species

Mesh:

Substances:

Year:  2014        PMID: 25327779     DOI: 10.1111/febs.13123

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  60 in total

1.  15-Deoxy-Δ12,14-prostaglandin J2 alleviates hepatic ischemia-reperfusion injury in mice via inducing antioxidant response and inhibiting apoptosis and autophagy.

Authors:  Kan Chen; Jing-Jing Li; Sai-Nan Li; Jiao Feng; Tong Liu; Fan Wang; Wei-Qi Dai; Yu-Jing Xia; Jie Lu; Ying-Qun Zhou; Chuan-Yong Guo
Journal:  Acta Pharmacol Sin       Date:  2017-02-20       Impact factor: 6.150

2.  miR-214 Down-Regulation Promoted Hypoxia/Reoxygenation-Induced Hepatocyte Apoptosis Through TRAF1/ASK1/JNK Pathway.

Authors:  Xinli Huang; Yun Gao; Jianjie Qin; Sen Lu
Journal:  Dig Dis Sci       Date:  2018-12-17       Impact factor: 3.199

Review 3.  Liver macrophages in tissue homeostasis and disease.

Authors:  Oliver Krenkel; Frank Tacke
Journal:  Nat Rev Immunol       Date:  2017-03-20       Impact factor: 53.106

4.  Sevoflurane attenuates cardiomyocyte apoptosis by mediating the miR-219a/AIM2/TLR4/MyD88 axis in myocardial ischemia/reperfusion injury in mice.

Authors:  Yan Li; Na Xing; Jingjing Yuan; Jianjun Yang
Journal:  Cell Cycle       Date:  2020-05-23       Impact factor: 4.534

5.  Taurine Alleviates Schistosoma-Induced Liver Injury by Inhibiting the TXNIP/NLRP3 Inflammasome Signal Pathway and Pyroptosis.

Authors:  Xin Liu; Ya-Rong Zhang; Chen Cai; Xian-Qiang Ni; Qing Zhu; Jin-Ling Ren; Yao Chen; Lin-Shuang Zhang; Chang-Ding Xue; Jie Zhao; Yong-Fen Qi; Yan-Rong Yu
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

Review 6.  Innate Immune Regulations and Liver Ischemia-Reperfusion Injury.

Authors:  Ling Lu; Haoming Zhou; Ming Ni; Xuehao Wang; Ronald Busuttil; Jerzy Kupiec-Weglinski; Yuan Zhai
Journal:  Transplantation       Date:  2016-12       Impact factor: 4.939

7.  Anti-inflammatory interventions-what has worked, not worked, and what may work in the future.

Authors:  Fatemeh Fattahi; Peter A Ward
Journal:  Transl Res       Date:  2015-08-14       Impact factor: 7.012

Review 8.  Inflammasome activation and function in liver disease.

Authors:  Gyongyi Szabo; Jan Petrasek
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-06-09       Impact factor: 46.802

Review 9.  Therapeutics administered during ex vivo liver machine perfusion: An overview.

Authors:  Julianna E Buchwald; Jing Xu; Adel Bozorgzadeh; Paulo N Martins
Journal:  World J Transplant       Date:  2020-01-18

Review 10.  Danger signals in liver injury and restoration of homeostasis.

Authors:  Hui Han; Romain Desert; Sukanta Das; Zhuolun Song; Dipti Athavale; Xiaodong Ge; Natalia Nieto
Journal:  J Hepatol       Date:  2020-05-01       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.